The Global OTC Cough, Cold and Allergy Medicine Market Is Poised to Increase at a CAGR of 4.9% During 2017 to 2022 to Reach a Valuation of Around US $37,300 Mn
A large number of people across the globe purchase OTC (over-the-counter) medicines for treating minor cough, cold or allergy related problems rather visiting the doctor. This has been a major reason behind the incessant sales of OTC cough, cold and allergy drugs. Many of the medicines for cold, cough and allergy fall under common categories of OTC. In order to ensure customer safety, healthcare regulatory bodies in some countries have even set guidelines for selling or purchasing of such medicines....
View full press release